Leader in AI powered Drug Development and Precision Medicine Superior Science and Risk-Sharing Business Models DYNAMIKA, Cloud AI-Powered Platform for Data Management Smart Imaging Strategy to Accelerate Drug Development

NEWS

DAVIX as a Surrogate Outcome Measure for Scleroderma Patients.

The Lancet Rheumatology publishes the data from the prospective study.

Dr. Olga Kubassova, CEO of IAG Joins Business Leaders in London.

During the Inflexion’s Event for Women Business Leaders on 27th Sept. 2023.

Apremilast Reduces Inflammation as Measured by MRI – oral presentation

at the Congress of Clinical Rheumatology (CCR-West) 2023 September 7th-10th

IAG Team to Attend ASBMR 2023: Advancing Bone and Mineral Research

Join us at ASBMR 2023 in Vancouver, BC, Canada, October 13-16 2023.

IAG Team will Join Discussions at LSX World Congress USA in Boston

Join us at LSX World Congress September 13-14, 2023 Boston

Apremilast Reduces Inflammation as Measured by MRI – oral presenation

at Scandinavian Congress of Rheumatology (SCR) 2023.

International Workshop on Osteoarthritis Imaging’23

Meet Dr. Kubassova, Prof. Boesen, Dr Iakimov and Dr Carrino of IAG.

Join Our Bio-Partnering Team at BIO International Convention!

Join us at BIO International Convention in Boston 5th-8th June 2023

VIEWS

Cartilage Repair: Imaging in Treatment Advancements

Critical Role of Imaging is Crucial in Drug Development

Getting approval: the EMA and the FDA

Thinking through drug approval: the FDA and EMA and their requirements.

Imaging Power in Alzheimer’s Disease (AD) Studies

Breakthroughs in AD research and trials rely on accurate imaging and its interpretation.

BioTech Investing in 2022, Jefferies Conference Reflections

The world saw unprecedented growth in healthcare investing in 2021.

The Promise of Precision Oncology

Artificial Intelligence advancing clinical studies.

Power of Radiomics: Can We Predict Treatment Response to Immunotherapy?

Increase the scientific value of clinical trials and accelerate the drug to market process.

If you aim to disrupt an industry, you must be willing to disrupt yourself

Why embracing digital transformation in drug development is the Leader’s’ job.

Central Imaging in Successful Oncology Clinical Trials

Central imaging in successful oncology clinical trials.

IAG, Image Analysis Group

IAG brings radiological expertise and artificial intelligence in a meaningful way to imaging processes, accelerating the power and speed of critical decision making within clinical drug development.

DYNAMIKA, IAG’s Cloud Platform 

IAG’s proprietary platform DYNAMIKA supports seamless data collection, real-time Quality Contol, real-time data analytics and real time data ingestion. This allow for a fully transparent real-time data management and trial execution control. ISO Certified, GCP, HIPPA, FDA, 21 CFR part 11

Global Client Services: Clinical Trials

IAG’s project, site support and data teams are located in USA, EU and Asia. We strategically use radiology imaging, analytics, AI and technology to accelerate drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a successful H2H or superiority trial, our science, operations and technology teams will work with you to develop the right solution.

Webinars:
Our Publications

Since 2007, over 2000 articles were published to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.